Inflammation News and Research

RSS

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool.

From Siemens Healthineers Laboratory Diagnostics 17 Mar 2022

New guidance addresses how student athletes can safely return to play after COVID-19 infection

Student athletes ages 14-25 who experience COVID-19 infections need not undergo diagnostic testing for myocarditis in the absence of cardiac symptoms, according to guidance published today by the American College of Cardiology.

16 Mar 2022

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

New research reveals factors that control the interplay of natural killer (NK) cells - which are part of the body's innate, or first line, immune response - with tumor cells, viral infections, and solid organ transplants.

16 Mar 2022

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine.

16 Mar 2022

New insight into how gut bacteria work to counter intestinal inflammation

Bile acids made by the liver have long been known for their critical role in helping to absorb the food we ingest.

16 Mar 2022

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Long term exposure to air pollution is linked to a heightened risk of autoimmune disease, particularly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, finds research published online in the open access journal RMD Open.

16 Mar 2022

Can cardiac biomarkers determine COVID-19 prognosis?

Researchers review prognostic cardiac biomarkers in COVID-19 patients.

15 Mar 2022

Serious COVID-19 linked to higher risk of long-term adverse mental health effects

A new study published in The Lancet Public Health journal indicates that serious COVID-19 illness is linked to an increase in the risk of long-term adverse mental health effects.

15 Mar 2022

Croup: A previously unrecognized complication of COVID-19 in young children

The omicron surge has led to a previously unrecognized complication of COVID-19 in young children: croup. In the first peer-reviewed report to date, physicians at Boston Children's Hospital describe 75 children who came to the hospital's emergency department (ED) with croup and COVID-19 from March 1, 2020 through January 15, 2022.

15 Mar 2022

Researchers receive grant to find answers to taste loss in COVID patients

Up to 80% of individuals who've had COVID-19 report temporary or lasting changes in their sense of taste, and scientists are working to better understand the biological basis of why, including whether our taste buds are a direct virus target.

15 Mar 2022

Immune cells could help predict the prognosis of patients with ALS

Immune cells could help predict the prognosis of patients with the rare neurological disease amyotrophic lateral sclerosis (ALS), says a study published today in eLife.

15 Mar 2022

Routine mammograms may provide clues for heart disease risk in postmenopausal women

Routine mammograms may provide key insights for cardiovascular disease. Detection of breast arterial calcifications on breast mammograms was associated with a higher risk of cardiovascular disease in postmenopausal women, according to new research published today in Circulation: Cardiovascular Imaging, a peer-reviewed journal of the American Heart Association journal.

15 Mar 2022

Researchers identify a potential new test for early diagnosis of Lyme disease

For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

Small airways disease is a potential long-lasting effect of COVID-19, study says

Disease of the small airways in the lungs is a potential long-lasting effect of COVID-19, according to a new study published in the journal Radiology.

15 Mar 2022

Study finds elevated inflammation in macrophages months after mild COVID-19

There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection.

15 Mar 2022

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

In a new study, scientists have evaluated if atrial fibrillation could be regarded as a comorbidity in relation to SARS-CoV-2 infection.

15 Mar 2022

Ozone exposure may increase depressive symptoms for adolescents over time

Exposure to ozone from air pollution has been linked to an increase in depressive symptoms for adolescents over time, even in neighborhoods that meet air quality standards, according to new research published by the American Psychological Association.

14 Mar 2022

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Around 500,000 people in the UK live with Inflammatory Bowel Disease (IBD), a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms.

14 Mar 2022

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Researchers analyze the available scientific evidence supporting vitamin D as a neuroprotective agent against the neurological sequelae of COVID-19.

14 Mar 2022

Inflammation News and Research

Siemens Healthineers launches Enhanced Liver Fibrosis (ELF) Test in the U.S.

New guidance addresses how student athletes can safely return to play after COVID-19 infection

Discovery of how NK cells are regulated in peripheral tissues could help combat cancer, other diseases

Toxin-producing yeast strains may damage the gut of patients with inflammatory bowel disease

New insight into how gut bacteria work to counter intestinal inflammation

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Can cardiac biomarkers determine COVID-19 prognosis?

Serious COVID-19 linked to higher risk of long-term adverse mental health effects

Croup: A previously unrecognized complication of COVID-19 in young children

Researchers receive grant to find answers to taste loss in COVID patients

Immune cells could help predict the prognosis of patients with ALS

Routine mammograms may provide clues for heart disease risk in postmenopausal women

Researchers identify a potential new test for early diagnosis of Lyme disease

High doses of antibiotic may safely and effectively treat TB meningitis

Small airways disease is a potential long-lasting effect of COVID-19, study says

Study finds elevated inflammation in macrophages months after mild COVID-19

The effect of SARS-CoV-2 infection on patients with a history of atrial fibrillation

Ozone exposure may increase depressive symptoms for adolescents over time

New computational biology method deciphers gut microbiome ‘chatter’ to fight IBD

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News